Background Orally effective therapeutics for plaque psoriasis with improved response rates,
lower toxicity and costs are needed in clinical practices. This study aims to assess the …

Psoriasis is a chronic inflammatory skin disease characterized by periods of remission and
relapse. In this pathology, keratinocytes, dendritic cells, and different subpopulations of T …

Purpose This real-world study investigated the impact of patient-reported disease burden
and health-related quality of life (HRQoL) on switching from systemic nonbiologic to biologic …

Plaque psoriasis (PsO) is a chronic immune‐mediated inflammatory disease with skin
lesions accompanied by an inflammation‐related comorbidity risk. The development of …

Methods We conducted a retrospective, non-interventional cohort study based on
anonymized claims data from the German statutory health insurance which covered the …

Background Empirical decisions to select therapies for psoriasis (PSO) and atopic dermatitis
(AD) can lead to delays in disease control and increased health care costs. However …

Objective: To compare the efficacy of methotrexate versus acitretin in the treatment of
chronic plaque psoriasis Method: Randomized controlled Trial conducted in Dermatology …

Background Biologics are therapeutic options for the management of moderate− severe
plaque psoriasis. Some patients need to switch biologic treatment to achieve satisfactory …

Conflict of interest: Ms. Spaulding was funded by the National Institute of Diabetes and
Digestive and Kidney Diseases of the National Institutes of Health under Award Number …

Objective To compare the efficacy of apremilast versus methotrexate in patients with
moderate to severe chronic plaque psoriasis. Methods Comparative Experimental Study …